CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Low bargaining power of suppliers
3.3.2. Low threat of new entrants
3.3.3. Low threat of substitutes
3.3.4. Low intensity of rivalry
3.3.5. Low bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of chronic diseases
3.4.1.2. Rise in geriatric population
3.4.1.3. Applications of IONM in various surgeries
3.4.2. Restraints
3.4.2.1. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Systems
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Accessories
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Insourced Monitoring
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Outsourced Monitoring
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Spinal Surgery
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Neurosurgery
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Orthopedic Surgery
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. ENT Surgery
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
6.6. Vascular Surgery
6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis by country
6.7. Other surgeries
6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis by country
CHAPTER 7: INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Motor evoked potentials (MEPs)
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Somatosensory evoked potentials (SSEPs)
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Electroencephalography (EEG)
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
7.5. Electromyography (EMG)
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis by country
7.6. Brainstem auditory evoked potentials (BAEPs)
7.6.1. Key market trends, growth factors and opportunities
7.6.2. Market size and forecast, by region
7.6.3. Market share analysis by country
7.7. Visual evoked potentials (VEPs)
7.7.1. Key market trends, growth factors and opportunities
7.7.2. Market size and forecast, by region
7.7.3. Market share analysis by country
CHAPTER 8: INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER
8.1. Overview
8.1.1. Market size and forecast
8.2. Hospitals
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by region
8.2.3. Market share analysis by country
8.3. Ambulatory Surgical Centers (ASCs)
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by region
8.3.3. Market share analysis by country
CHAPTER 9: INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast By Region
9.2. North America
9.2.1. Key market trends, growth factors and opportunities
9.2.2. Market size and forecast, by Products and Services
9.2.3. Market size and forecast, by Source Type
9.2.4. Market size and forecast, by Application
9.2.5. Market size and forecast, by Modality
9.2.6. Market size and forecast, by End User
9.2.7. Market size and forecast, by country
9.2.7.1. U.S.
9.2.7.1.1. Market size and forecast, by Products and Services
9.2.7.1.2. Market size and forecast, by Source Type
9.2.7.1.3. Market size and forecast, by Application
9.2.7.1.4. Market size and forecast, by Modality
9.2.7.1.5. Market size and forecast, by End User
9.2.7.2. Canada
9.2.7.2.1. Market size and forecast, by Products and Services
9.2.7.2.2. Market size and forecast, by Source Type
9.2.7.2.3. Market size and forecast, by Application
9.2.7.2.4. Market size and forecast, by Modality
9.2.7.2.5. Market size and forecast, by End User
9.2.7.3. Mexico
9.2.7.3.1. Market size and forecast, by Products and Services
9.2.7.3.2. Market size and forecast, by Source Type
9.2.7.3.3. Market size and forecast, by Application
9.2.7.3.4. Market size and forecast, by Modality
9.2.7.3.5. Market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors and opportunities
9.3.2. Market size and forecast, by Products and Services
9.3.3. Market size and forecast, by Source Type
9.3.4. Market size and forecast, by Application
9.3.5. Market size and forecast, by Modality
9.3.6. Market size and forecast, by End User
9.3.7. Market size and forecast, by country
9.3.7.1. Germany
9.3.7.1.1. Market size and forecast, by Products and Services
9.3.7.1.2. Market size and forecast, by Source Type
9.3.7.1.3. Market size and forecast, by Application
9.3.7.1.4. Market size and forecast, by Modality
9.3.7.1.5. Market size and forecast, by End User
9.3.7.2. France
9.3.7.2.1. Market size and forecast, by Products and Services
9.3.7.2.2. Market size and forecast, by Source Type
9.3.7.2.3. Market size and forecast, by Application
9.3.7.2.4. Market size and forecast, by Modality
9.3.7.2.5. Market size and forecast, by End User
9.3.7.3. UK
9.3.7.3.1. Market size and forecast, by Products and Services
9.3.7.3.2. Market size and forecast, by Source Type
9.3.7.3.3. Market size and forecast, by Application
9.3.7.3.4. Market size and forecast, by Modality
9.3.7.3.5. Market size and forecast, by End User
9.3.7.4. Italy
9.3.7.4.1. Market size and forecast, by Products and Services
9.3.7.4.2. Market size and forecast, by Source Type
9.3.7.4.3. Market size and forecast, by Application
9.3.7.4.4. Market size and forecast, by Modality
9.3.7.4.5. Market size and forecast, by End User
9.3.7.5. Spain
9.3.7.5.1. Market size and forecast, by Products and Services
9.3.7.5.2. Market size and forecast, by Source Type
9.3.7.5.3. Market size and forecast, by Application
9.3.7.5.4. Market size and forecast, by Modality
9.3.7.5.5. Market size and forecast, by End User
9.3.7.6. Rest of Europe
9.3.7.6.1. Market size and forecast, by Products and Services
9.3.7.6.2. Market size and forecast, by Source Type
9.3.7.6.3. Market size and forecast, by Application
9.3.7.6.4. Market size and forecast, by Modality
9.3.7.6.5. Market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors and opportunities
9.4.2. Market size and forecast, by Products and Services
9.4.3. Market size and forecast, by Source Type
9.4.4. Market size and forecast, by Application
9.4.5. Market size and forecast, by Modality
9.4.6. Market size and forecast, by End User
9.4.7. Market size and forecast, by country
9.4.7.1. Japan
9.4.7.1.1. Market size and forecast, by Products and Services
9.4.7.1.2. Market size and forecast, by Source Type
9.4.7.1.3. Market size and forecast, by Application
9.4.7.1.4. Market size and forecast, by Modality
9.4.7.1.5. Market size and forecast, by End User
9.4.7.2. China
9.4.7.2.1. Market size and forecast, by Products and Services
9.4.7.2.2. Market size and forecast, by Source Type
9.4.7.2.3. Market size and forecast, by Application
9.4.7.2.4. Market size and forecast, by Modality
9.4.7.2.5. Market size and forecast, by End User
9.4.7.3. India
9.4.7.3.1. Market size and forecast, by Products and Services
9.4.7.3.2. Market size and forecast, by Source Type
9.4.7.3.3. Market size and forecast, by Application
9.4.7.3.4. Market size and forecast, by Modality
9.4.7.3.5. Market size and forecast, by End User
9.4.7.4. Australia
9.4.7.4.1. Market size and forecast, by Products and Services
9.4.7.4.2. Market size and forecast, by Source Type
9.4.7.4.3. Market size and forecast, by Application
9.4.7.4.4. Market size and forecast, by Modality
9.4.7.4.5. Market size and forecast, by End User
9.4.7.5. South Korea
9.4.7.5.1. Market size and forecast, by Products and Services
9.4.7.5.2. Market size and forecast, by Source Type
9.4.7.5.3. Market size and forecast, by Application
9.4.7.5.4. Market size and forecast, by Modality
9.4.7.5.5. Market size and forecast, by End User
9.4.7.6. Rest of Asia-Pacific
9.4.7.6.1. Market size and forecast, by Products and Services
9.4.7.6.2. Market size and forecast, by Source Type
9.4.7.6.3. Market size and forecast, by Application
9.4.7.6.4. Market size and forecast, by Modality
9.4.7.6.5. Market size and forecast, by End User
9.5. LAMEA
9.5.1. Key market trends, growth factors and opportunities
9.5.2. Market size and forecast, by Products and Services
9.5.3. Market size and forecast, by Source Type
9.5.4. Market size and forecast, by Application
9.5.5. Market size and forecast, by Modality
9.5.6. Market size and forecast, by End User
9.5.7. Market size and forecast, by country
9.5.7.1. Brazil
9.5.7.1.1. Market size and forecast, by Products and Services
9.5.7.1.2. Market size and forecast, by Source Type
9.5.7.1.3. Market size and forecast, by Application
9.5.7.1.4. Market size and forecast, by Modality
9.5.7.1.5. Market size and forecast, by End User
9.5.7.2. Saudi Arabia
9.5.7.2.1. Market size and forecast, by Products and Services
9.5.7.2.2. Market size and forecast, by Source Type
9.5.7.2.3. Market size and forecast, by Application
9.5.7.2.4. Market size and forecast, by Modality
9.5.7.2.5. Market size and forecast, by End User
9.5.7.3. South Africa
9.5.7.3.1. Market size and forecast, by Products and Services
9.5.7.3.2. Market size and forecast, by Source Type
9.5.7.3.3. Market size and forecast, by Application
9.5.7.3.4. Market size and forecast, by Modality
9.5.7.3.5. Market size and forecast, by End User
9.5.7.4. Rest of LAMEA
9.5.7.4.1. Market size and forecast, by Products and Services
9.5.7.4.2. Market size and forecast, by Source Type
9.5.7.4.3. Market size and forecast, by Application
9.5.7.4.4. Market size and forecast, by Modality
9.5.7.4.5. Market size and forecast, by End User
CHAPTER 10: COMPETITIVE LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product mapping of top 10 player
10.4. Competitive dashboard
10.5. Competitive heatmap
10.6. Top player positioning, 2022
CHAPTER 11: COMPANY PROFILES
11.1. NuVasive, Inc.
11.1.1. Company overview
11.1.2. Key executives
11.1.3. Company snapshot
11.1.4. Operating business segments
11.1.5. Product portfolio
11.1.6. Business performance
11.2. Medtronic plc
11.2.1. Company overview
11.2.2. Key executives
11.2.3. Company snapshot
11.2.4. Operating business segments
11.2.5. Product portfolio
11.2.6. Business performance
11.2.7. Key strategic moves and developments
11.3. Computational Diagnostics, Inc.
11.3.1. Company overview
11.3.2. Key executives
11.3.3. Company snapshot
11.3.4. Operating business segments
11.3.5. Product portfolio
11.4. Natus Medical Incorporated.
11.4.1. Company overview
11.4.2. Key executives
11.4.3. Company snapshot
11.4.4. Operating business segments
11.4.5. Product portfolio
11.4.6. Business performance
11.5. Accurate Monitoring
11.5.1. Company overview
11.5.2. Key executives
11.5.3. Company snapshot
11.5.4. Operating business segments
11.5.5. Product portfolio
11.6. inomed Medizintechnik GmbH
11.6.1. Company overview
11.6.2. Key executives
11.6.3. Company snapshot
11.6.4. Operating business segments
11.6.5. Product portfolio
11.7. Nihon Kohden Corporation
11.7.1. Company overview
11.7.2. Key executives
11.7.3. Company snapshot
11.7.4. Operating business segments
11.7.5. Product portfolio
11.7.6. Business performance
11.8. SpecialtyCare
11.8.1. Company overview
11.8.2. Key executives
11.8.3. Company snapshot
11.8.4. Operating business segments
11.8.5. Product portfolio
11.9. Intranerve Neuroscience Holdings, LLC
11.9.1. Company overview
11.9.2. Key executives
11.9.3. Company snapshot
11.9.4. Operating business segments
11.9.5. Product portfolio
11.9.6. Key strategic moves and developments
11.10. NeuroStyle Pte.Ltd
11.10.1. Company overview
11.10.2. Key executives
11.10.3. Company snapshot
11.10.4. Operating business segments
11.10.5. Product portfolio
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
